Bedel Financial Consulting Inc. Sells 1,385 Shares of CVS Health Corp (NYSE:CVS)

Bedel Financial Consulting Inc. lessened its stake in CVS Health Corp (NYSE:CVS) by 52.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,279 shares of the pharmacy operator’s stock after selling 1,385 shares during the period. Bedel Financial Consulting Inc.’s holdings in CVS Health were worth $76,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cornerstone Wealth Group LLC lifted its stake in shares of CVS Health by 4.0% in the 1st quarter. Cornerstone Wealth Group LLC now owns 36,744 shares of the pharmacy operator’s stock valued at $2,180,000 after acquiring an additional 1,430 shares during the last quarter. National Asset Management Inc. lifted its stake in shares of CVS Health by 17.1% in the 1st quarter. National Asset Management Inc. now owns 60,000 shares of the pharmacy operator’s stock valued at $3,561,000 after acquiring an additional 8,777 shares during the last quarter. Mcdaniel Terry & Co. lifted its stake in shares of CVS Health by 8.5% in the 1st quarter. Mcdaniel Terry & Co. now owns 171,077 shares of the pharmacy operator’s stock valued at $10,150,000 after acquiring an additional 13,401 shares during the last quarter. Frisch Financial Group Inc. lifted its stake in shares of CVS Health by 12.9% in the 1st quarter. Frisch Financial Group Inc. now owns 73,088 shares of the pharmacy operator’s stock valued at $4,336,000 after acquiring an additional 8,379 shares during the last quarter. Finally, Staley Capital Advisers Inc. lifted its stake in shares of CVS Health by 2.3% in the 1st quarter. Staley Capital Advisers Inc. now owns 858,752 shares of the pharmacy operator’s stock valued at $50,950,000 after acquiring an additional 19,158 shares during the last quarter. 76.44% of the stock is owned by institutional investors.

Shares of CVS Health stock traded down $0.05 during midday trading on Friday, hitting $63.29. The company had a trading volume of 1,549,806 shares, compared to its average volume of 8,176,636. The company has a debt-to-equity ratio of 1.29, a quick ratio of 0.70 and a current ratio of 0.99. The stock has a market capitalization of $82.63 billion, a P/E ratio of 11.47, a P/E/G ratio of 1.42 and a beta of 0.73. The company has a 50 day moving average of $61.03 and a 200 day moving average of $67.63. CVS Health Corp has a 52-week low of $52.04 and a 52-week high of $77.03.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $1.91 earnings per share for the quarter, topping the consensus estimate of $1.63 by $0.28. The company had revenue of $66.76 billion for the quarter, compared to the consensus estimate of $64.11 billion. CVS Health had a return on equity of 15.17% and a net margin of 2.76%. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.62 EPS. Equities research analysts forecast that CVS Health Corp will post 7.08 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were paid a $0.50 dividend. The ex-dividend date was Wednesday, April 22nd. This represents a $2.00 annualized dividend and a dividend yield of 3.16%. CVS Health’s payout ratio is currently 28.25%.

In other CVS Health news, EVP Alan Lotvin bought 5,000 shares of the business’s stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $63.14 per share, for a total transaction of $315,700.00. Following the purchase, the executive vice president now owns 15,161 shares in the company, valued at approximately $957,265.54. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP James David Clark sold 6,234 shares of the stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $65.00, for a total value of $405,210.00. Following the sale, the senior vice president now owns 4,817 shares in the company, valued at $313,105. The disclosure for this sale can be found here. Corporate insiders own 0.46% of the company’s stock.

CVS has been the subject of a number of recent research reports. Deutsche Bank boosted their target price on CVS Health from $97.00 to $109.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Robert W. Baird upped their price target on CVS Health from $62.00 to $66.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. SunTrust Banks lowered their price target on CVS Health from $90.00 to $80.00 and set a “buy” rating for the company in a research report on Monday, April 13th. UBS Group lowered their price target on CVS Health from $85.00 to $79.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Finally, Tigress Financial reaffirmed a “buy” rating on shares of CVS Health in a research report on Friday, April 24th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. CVS Health currently has an average rating of “Buy” and an average price target of $80.88.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: How does a 12b-1 fee affect fund performance?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit